Skip to main content
Loading

LBL Biotech Inc.

October 17, 2023
Franciscan C
Oncology
LBL Biotec. Inc. is a spin-off company from National Cheng-kung University at Taiwan. The company focusses on the development of IL-20 antibody to treat several inflammation-associated diseases such as pancreatic cancer ( PDAC), hepatoma, breast cancer etc. The drug is currently in the phase 1/2A human clinical trial on patients with solid tumors.
Speakers
Mingshi Chang - LBL Biotech Inc.